AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Scope & Guideline
Advancing Clinical Insights for Healthier Skin
Introduction
Aims and Scopes
- Clinical Efficacy and Safety of Treatments:
The journal frequently publishes studies evaluating the clinical efficacy and safety of various dermatological treatments, including biologics, JAK inhibitors, and traditional therapies, using randomized controlled trials and real-world evidence. - Innovative Diagnostic and Therapeutic Approaches:
Research on innovative diagnostic techniques and therapeutic strategies, particularly in the context of emerging technologies like artificial intelligence and personalized medicine, is a consistent focus. - Pathophysiology of Skin Diseases:
The journal emphasizes understanding the underlying mechanisms of various skin diseases, including autoimmune conditions, inflammatory disorders, and skin cancers, providing insights that inform treatment. - Patient-Centered Care and Quality of Life:
The journal highlights the importance of patient-reported outcomes and quality of life in dermatological practice, advocating for approaches that consider the holistic impact of skin diseases on patients. - Emerging Trends in Dermatology:
The publication regularly addresses emerging trends and challenges in dermatology, including the impact of systemic diseases on skin health, the role of comorbidities, and the implications of climate change on dermatologic conditions.
Trending and Emerging
- Biologics and Targeted Therapies:
There is a significant increase in research dedicated to biologics and targeted therapies, particularly for chronic conditions like psoriasis and atopic dermatitis, highlighting their clinical efficacy and safety in diverse patient populations. - Artificial Intelligence in Dermatology:
The integration of artificial intelligence in diagnostic processes and patient management is on the rise, showcasing its potential to transform dermatological practices through enhanced accuracy and efficiency. - Impact of Comorbidities on Skin Diseases:
Emerging studies are increasingly exploring the relationship between skin conditions and systemic comorbidities, reflecting a growing understanding of how overall health influences dermatological outcomes. - Personalized Medicine Approaches:
There is a trend towards personalized medicine in dermatology, with research focusing on tailoring treatments based on individual patient characteristics, including genetic profiles and specific disease presentations. - Psychosocial Aspects and Quality of Life:
An increasing emphasis on the psychosocial aspects of skin diseases, including their impact on quality of life and mental health, indicates a broader approach to patient care that goes beyond physical symptoms.
Declining or Waning
- Traditional Therapeutics:
There is a noticeable decrease in publications centered around traditional dermatological treatments, such as topical corticosteroids and older systemic therapies, as newer biologics and targeted therapies gain attention. - General Reviews without New Insights:
General literature reviews lacking novel insights or updates on treatment paradigms have become less common, as the journal increasingly favors studies that present original research findings or significant advances. - Epidemiological Studies of Common Conditions:
Research focusing on the epidemiology of common dermatological conditions appears to be waning, possibly due to a shift toward more specific and mechanistic studies that delve deeper into pathophysiology. - Pharmacovigilance Studies:
Although important, studies focused solely on pharmacovigilance and adverse event reporting are less frequently featured, as the journal prioritizes comprehensive clinical trials and real-world efficacy studies.
Similar Journals
CLINICAL AND EXPERIMENTAL DERMATOLOGY
Bridging the Gap Between Clinical and Experimental Dermatology.CLINICAL AND EXPERIMENTAL DERMATOLOGY is a prominent journal in the field of dermatology, published by Oxford University Press. With an ISSN of 0307-6938 and an E-ISSN of 1365-2230, this journal has been a vital resource for researchers and practitioners since its inception in 1976. Recognized as a Q2 journal within the category of dermatology for 2023, it holds a respectable position, ranking #54 among 142 journals in this discipline, placing it in the 62nd percentile on Scopus. The journal is dedicated to publishing high-quality research that spans clinical and experimental aspects of dermatological science, making it an essential source of knowledge for advancing understanding and treatment of skin disorders. Although it operates on a traditional subscription model without open access options, its contributions to the field are significant, influencing both clinical practices and academic research. Researchers, clinicians, and students alike will find vital insights and contemporary themes presented in its pages, supporting ongoing education and innovation in dermatology.
Actas Dermo-Sifiliograficas
Unlocking the Future of Skin Research and PracticeActas Dermo-Sifiliograficas, published by Elsevier España, stands as a pivotal resource in the realms of dermatology, histology, and pathology and forensic medicine. With its ISSN of 0001-7310 and E-ISSN 1578-2190, this esteemed journal has transitioned to an Open Access model since 2020, facilitating broader dissemination of impactful research. Operating from its Madrid headquarters, it has been a vital platform for scholarly exchange since its inception in 1945, continuing through its converged years until 2024. The journal holds a Q3 ranking in dermatology, histology, and pathology and forensic medicine as of 2023, reflecting its relevance in the academic community where it ranks 79th in dermatology and 126th in pathology among its peers. With a commitment to advancing knowledge and practice in its fields, Actas Dermo-Sifiliograficas serves as an essential repository for researchers, professionals, and students seeking to engage with the latest findings and innovative perspectives in skin and disease research.
Annals of Dermatology
Innovating skin health through rigorous scholarship.Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.
AKTUELLE DERMATOLOGIE
Bridging Gaps in Dermatological Education and ResearchAKTUELLE DERMATOLOGIE is a distinguished journal in the field of Dermatology, published by GEORG THIEME VERLAG KG in Germany. With a commitment to advancing knowledge and practice in dermatological science, the journal has regularly featured research articles, reviews, and case studies since its inception in 1975 and continues to publish contributions through 2024. Despite being categorized in the lower quartile (Q4) of dermatology journals and holding a Scopus rank of #127 out of 142, it plays a pivotal role in disseminating valuable insights that support ongoing education and research in the discipline. The journal provides an essential platform for both seasoned professionals and budding researchers to share their findings, explore emerging trends, and discuss clinical practices, all while serving the needs of an evolving medical landscape. Access to its content may be restricted, but the journal remains a crucial reference for those invested in the future of dermatological research and patient care.
Dermatologie
Pioneering Insights in Dermatological ScienceDermatologie, published by SPRINGER HEIDELBERG, is a prominent journal dedicated to the advancing field of dermatology. With its ISSN 2731-7005 and E-ISSN 2731-7013, this journal has established itself as a valuable resource for researchers, professionals, and students alike. Originating in Germany, the journal focuses on disseminating innovative research from 2022 to 2024, contributing significantly to the understanding of skin health and disease management. Despite its current ranking within the Q3 category in dermatology and a Scopus rank of #88/142, it provides critical insights and advances in clinical practice, epidemiology, and therapeutic modalities. With an emphasis on open discourse, it seeks to foster collaboration among healthcare professionals and researchers, thereby enhancing the quality and accessibility of dermatological research. Engage with Dermatologie to stay at the forefront of the latest advancements in skin-related health issues.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
Fostering Excellence in Skin Research and PracticeANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE is a distinguished journal that serves as a vital platform for disseminating innovative research and insightful reviews in the field of dermatology and venereology. Published by MASSON EDITEUR, this journal has been a cornerstone for professionals and researchers since its inception in 1977, offering a wealth of knowledge that spans decades. With its ISSN 0151-9638 and E-ISSN 2214-5451, it is indexed within leading databases, ensuring that the published work reaches a broad audience. The journal currently holds a Q3 ranking in the dermatology category, reflecting its commitment to quality and rigorous peer-review processes. While the journal is not open access, it provides an extensive archive of valuable studies that contribute to advancements in skin health and treatment methodologies. Located in Issy-les-Moulineaux, France, ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE continues to attract submissions from esteemed professionals, enhancing its reputation as a crucial resource for those dedicated to the ongoing development of dermatological sciences.
Dermatologic Therapy
Exploring the complexities of dermatology for better patient outcomes.Dermatologic Therapy is a leading peer-reviewed journal published by WILEY-HINDAWI that focuses on the multifaceted field of dermatology. Established in 1996 and continuing its profound impact into 2024, the journal has earned an impressive Q1 rating in Dermatology and ranks 11th out of 142 in the Scopus categorization, placing it in the 92nd percentile. With its headquarters in the United Kingdom, the journal's mission is to advance the understanding and treatment of skin diseases through the dissemination of high-quality research, reviews, and clinical information. Although not an open-access journal, it provides extensive access options to ensure that vital research reaches its audience. By leading scholarly discourse and innovation in dermatological treatments, Dermatologic Therapy serves as an essential resource for researchers, clinicians, and students dedicated to improving skin health worldwide.
BRITISH JOURNAL OF DERMATOLOGY
Leading the way in dermatology innovation.The British Journal of Dermatology, published by Oxford University Press, stands as a premier platform for advancing the field of dermatological research and clinical practice since its inception in 1892. With a strong commitment to disseminating high-quality research, this esteemed journal is currently ranked in the Q1 category for both Dermatology and Miscellaneous Medicine in 2023, reflecting its influential position in the academic landscape. As the leading journal in its field, it enjoys a robust Scopus ranking of #1 out of 142 in dermatology, placing it in the 99th percentile globally. The journal covers a wide scope of subjects pertinent to dermatology, including clinical trials, treatment innovations, and epidemiological studies, making it an essential resource for researchers, healthcare professionals, and students alike. Although it is not an open-access publication, it ensures a broad reach through institutional subscriptions, fostering knowledge exchange across the global dermatological community. Based in the heart of the United Kingdom, the British Journal of Dermatology continues to play a crucial role in shaping the future of skin health and disease management.
DERMATOLOGY
Elevating knowledge in dermatology since 1893.DERMATOLOGY, an esteemed journal published by KARGER, is a vital resource in the field of dermatological research and clinical practice. Established in 1893, with its comprehensive coverage extending to 2024, this journal has earned its place as a leading publication, holding a prestigious Q1 quartile ranking in Dermatology and ranking 15th out of 142 in the Scopus Medicine - Dermatology category, reflecting its 89th percentile standing within the discipline. The journal aims to disseminate innovative research findings, critical reviews, and clinical studies that advance the understanding of skin disorders and their treatments. While primarily available through institutional subscriptions, DERMATOLOGY remains committed to enhancing accessibility and fostering international collaboration among researchers, professionals, and students in the dermatological community. Its rigorous peer-review process guarantees the highest quality of published works, making it an essential reference for those dedicated to advancing dermatological science and improving patient care.
Acta Dermatovenerologica Croatica
Innovating Treatments, Enhancing LivesActa Dermatovenerologica Croatica is a premier journal dedicated to the fields of dermatology and venereology, published by the Croatian Dermatovenereological Society. Established in 1994, this journal has been a vital platform for disseminating research and advancements in the understanding and treatment of skin diseases and sexually transmitted infections. Although it is currently classified in the Q4 quartile for dermatology, infectious diseases, and miscellaneous medicine, it provides a unique opportunity for emerging researchers and seasoned professionals to contribute to a growing body of knowledge. Based in Zagreb, Croatia, the journal emphasizes free access to information that enhances clinical practices and scientific understanding among dermatologists and venereologists worldwide. As the journal approaches its 30th anniversary, it continues to aim for excellence in research quality, fostering collaboration, and innovating in the ever-evolving fields it represents.